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Gut microbiotaMicroRNAs (miRNAs) are small non-coding RNAs with a central role in the post-transcriptional
control of gene expression, that have been implicated in a wide-range of biological processes.
Regulation of miRNA expression is increasingly recognized as a crucial part of the host response
to infection by bacterial pathogens, as well as a novel molecular strategy exploited by bacteria to
manipulate host cell pathways. Here, we review the current knowledge of bacterial pathogens that
modulate host miRNA expression, focusing onmammalian host cells, and the implications of miRNA
regulation on the outcome of infection. The emerging role of commensal bacteria, as part of the gut
microbiota, on host miRNA expression in the presence or absence of bacterial pathogens is also
discussed.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MicroRNAs (miRNAs) are a class of genome-encoded small
RNAs, typically 20–22 nt in length, which post-transcriptionally
repress the expression of cellular mRNAs [1,2]. In the canonical
biogenesis pathway, miRNA genes are transcribed by RNA
Polymerase II into a primary precursor (pri-miRNA), and then pro-
cessed in two steps catalyzed by members of the RNAse III family
of enzymes, Drosha and Dicer. In the ﬁrst step, inside the nucleus,
the Microprocessor complex (composed of the enzyme Drosha
and the RNA-binding protein DGCR8) processes the pri-miRNA into
a precursor hairpin of ca. 70 nt (pre-miRNA), which is then
exported to the cytoplasm by Exportin-5. The pre-miRNA is subse-
quently cleaved by Dicer to yield a miRNA duplex of approximately
20 bp.
To perform their regulatory functions, one of the strands of the
miRNA duplex assembles with the Argonaute and GW182 (TNRC6
in mammals) proteins into the RNA-induced silencing complex
(RISC); miRNA-loaded RISC can also be referred as miRISC. MiRNAs
repress the expression of cellular mRNAs containing partially com-
plementary binding sites, present mostly within the 30-UTR and
coding sequence of target transcripts. The ‘seed region’, a region
of 6–8 nt at the 50-end of miRNAs is the main determinant of targetspeciﬁcity. MiRNA families are deﬁned by a common seed
sequence, and are thus expected to regulate a largely overlapping
set of targets. Despite the important role of miRNAs as regulators
of gene expression, the mechanism by which miRNAs repress tar-
get gene expression remains controversial and the subject of
extensive research. The emerging consensus in the ﬁeld is that
miRNAs act mainly by repressing translation and promoting dead-
enylation and subsequent degradation of target mRNAs [3,4].
According to the latest release of miRBase, the public repository
of miRNA sequences, 30424 mature miRNAs have been reported
in 206 species; 2578 unique mature miRNAs are currently
annotated in the human genome, many of which showing a high
degree of conservation across species (miRBase 20.0, June 2013,
www.mirbase.org). Considering that individual miRNAs can have
hundreds of targets, it has been predicted that miRNAs can
regulate up to 60% of the human transcriptome [5]. However,
pinpointing the relevant targets responsible for a given phenotype
remains a difﬁcult challenge. Consistent with a major role in post-
transcriptional control of gene expression, miRNAs have been
shown to participate in a wide range of biological processes,
including development, cellular differentiation, proliferation,
apoptosis, metabolism and immune response [6–8]. In recent
years, it has become clear that miRNA biogenesis is tightly
regulated at the levels of transcription and processing, in a cell type
speciﬁc and developmentally controlled fashion [2,9]. Early studies
of miRNAs described their expression proﬁles in disease-relevant
cells and tissues and revealed a correlation between altered
miRNA expression and several pathologies, including cancer,
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increased the interest in using miRNA expression proﬁles for
disease diagnosis and prognosis, as well as the use of miRNA
mimics or inhibitors as therapeutics.
MiRNAs have also been shown to play crucial roles during infec-
tion by diverse pathogens, including viruses, parasites and bacteria
(reviewed in [13–15]). Seminal work on the role of miRNAs in host-
pathogen interactions focused on virus infections. Initial miRNA
proﬁling experiments revealed that several DNA viruses (herpesvi-
rus, polyomavirus and adenovirus) express multiple miRNAs in
infected cells to manipulate the levels of both viral and cellular
mRNAs, thereby inﬂuencing viral replication and pathogenesis
[15]. In addition to virus-encoded miRNAs with roles in infection,
several host cell miRNAs that either repress or enhance the replica-
tion of different viruses have been identiﬁed. Viruses have also
been shown to modulate the levels of host miRNAs, mainly
through the expression of viral suppressor proteins that antagonize
the small RNA-directed immunity of the host [16].
Considerably less is known about the effect of bacterial patho-
gens on host miRNA expression, as well as the reciprocal effect,
i.e. the role of host cell miRNAs on modulating bacterial infections.
The ﬁrst evidence of miRNA regulation as a result of bacterial infec-
tion was obtained upon infection of the plant Arabidopsis thaliana
with the extracellular pathogen Pseudomonas syringae [17]. Specif-
ically, infection was shown to induce the transcription of miR-
393a, which represses the receptor for the hormone auxin, a nega-
tive regulator of plant defense. In this case, up-regulation of miR-
393a contributes to the resistance of the plant against the bacterial
pathogen. To counteract this antibacterial defense mechanism, P.
syringae secretes effector proteins into the host cell, which are able
to suppress transcription, processing or activity of host miRNAs
[18].
The miRNA response of mammalian cells to infection was ini-
tially inferred from a pioneering study that investigated the
expression of a panel of ca. 200 miRNAs in human monocytes fol-
lowing stimulation with the bacterial wall component lipopolysac-
charide (LPS), which is primarily sensed by Toll-like receptor 4
(TLR4) [19]. This analysis revealed the up-regulation of miR-132,Immune res
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Fig. 1. Overview of selected host mammalian miRNAs regulated by representative bac
intracellular), Helicobacter (Gram-negative, extracellular/intracellular) and MycobacteriamiR-146a/b and miR-155. These and subsequent ﬁndings showed
that both miR-146 and miR-155 targeted mRNAs in the signaling
cascade downstream of TLR4, leading to a model in which these
two miRNAs facilitate a negative-feedback loop that may protect
host cells from an excessive TLR4 response.
This review aims to provide an overview of the current knowl-
edge on the role of miRNAs during infection by different bacterial
pathogens and in response to commensal bacteria, focusing on
mammalian host cells.
2. MicroRNA responses to pathogenic bacteria
Although the vast majority of bacteria are innocuous or even
beneﬁcial to mammalian hosts, bacterial pathogens are the causa-
tive agents of several relevant diseases worldwide, such as food-
borne illnesses caused by Listeria monocytogenes and Salmonella
species, peptic ulcers and gastric cancers associated with Helico-
bacter pylori and tuberculosis caused by Mycobacterium tuberculo-
sis. To ensure their survival and replication, bacterial pathogens
manipulate a wide range of host cellular functions/pathways
through the delivery of effector proteins into host cells [20,21].
Regulation of miRNA expression upon infection by bacterial patho-
gens is emerging as a crucial part of the host response to infection,
as well as a novel molecular strategy exploited by bacteria to con-
trol host cell pathways. The sections below and Fig. 1 review the
current literature on the regulation of host miRNAs by different
bacterial pathogens.
3. Listeria monocytogenes
L. monocytogenes is a Gram-positive facultative intracellular
pathogen that can cause gastroenteritis in healthy individuals,
and serious illnesses in immunocompromised individuals and
pregnant women [22]. Upon entry in phagocytic or non-phagocytic
cells, L. monocytogenes readily escapes the bacteria-containing vac-
uole in a process mediated by the pore-forming toxin listeriolysin-
O (LLO), moves in the host cell cytoplasm and efﬁciently spreads to
neighboring cells [22]. This foodborne pathogen has been used as aponse
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expression in infected host cells.
Genome-wide miRNA expression proﬁling in mouse bone
marrow derived macrophages infected with L. monocytogenes iden-
tiﬁed the immune-related miRNAs miR-155, miR-146a, miR-125a-
3p/5p and miR-149 as being signiﬁcantly induced upon infection
[23]. Interestingly, these ﬁve miRNAs were also up-regulated upon
infection with the LLO-deﬁcient mutant, suggesting that extracel-
lular sensing of L. monocytogenes is sufﬁcient to stimulate miRNA
expression. These miRNAs, which target genes involved in the
innate immune response such as SHIP1, TRAF6 and IRAK1, are
likely to be involved in the regulation of the innate immune
response against L. monocytogenes.
The effect of L. monocytogenes infection on miRNA expression
has also been studied in human intestinal epithelial cells (Caco-2
cells) [24]. Similarly to what has been observed in macrophages,
the expression of miR-155 was strongly increased in Caco-2 cells;
miR-146b and miR-16 were also induced upon infection, albeit to a
lesser extent. Strikingly, the up-regulation of these miRNAs could
be fully recapitulated upon treatment of epithelial cells with
puriﬁed LLO. Infection by L. monocytogenes also led to the down-
regulation of let-7a and miR-145 in Caco-2 cells [24]. MiR-145
has been predicted to target IFN-b, a cytokine with anti-inﬂamma-
tory properties that was shown to be beneﬁcial to L. monocytogenes
infection [25,26]. Moreover, inhibition of miR-145 expression was
shown to inhibit inﬂammatory responses, notably the production
of the pro-inﬂammatory cytokines IL-5 and IL-13 [27]. Down-
regulation of this miRNA could thus constitute a mechanism by
which L. monocytogenes dampens the host immune response to
facilitate its intracellular survival.
Modulation of miRNA expression in response to Listeria infec-
tion was also shown to occur in vivo. During systemic infection
of mice with L. monocytogenes, miR-29 has been shown to be
down-regulated in natural killer (NK) cells [28]. Ma et al. hypoth-
esized that inhibition of miR-29 can potentiate the immune
response directed against Listeria, due to the increased expression
of its target IFN-c, leading to a more effective clearance of the bac-
teria. L. monocytogeneswas also shown to modulate the expression
of miRNAs in the ileum of orally infected mice, in particular miR-
143, miR-148a, miR-200b and miR-200c [29]. Interestingly, this
effect was dependent on the gut microbiota (see below).
4. Salmonella Typhimurium
Salmonella enterica serovar Typhimurium (Salmonella) is an
extensively studied Gram-negative, facultative intracellular patho-
gen, and one of the most common causes of gastroenteritis in
humans [30]. Salmonella can infect both phagocytic and non-phag-
ocytic cells, where it resides inside the so-called Salmonella con-
taining vacuole (SCV). For invasion of host cells and intracellular
replication, Salmonella secretes more than 30 effector proteins into
the host cytoplasm, through two distinct type-III secretion systems
(T3SS). These effectors modulate various host cellular pathways
necessary for productive infection [31,32].
Modulation of the host miRNA repertoire by Salmonella infec-
tion was ﬁrst described in mouse macrophages, where the NF-jB
dependent miRNAs miR-155, miR-146a/b and miR-21, were shown
to be strongly induced upon infection [33]. These miRNAs were
also regulated upon infection with Salmonella mutant strains
defective in cell invasion (DSPI-1) and/or replication (DSPI-2), as
well as upon treatment of cells with puriﬁed Salmonella LPS, dem-
onstrating that regulation of these miRNAs is triggered by the sens-
ing of an extracellular stimulus. Up-regulation of these miRNAs
was also observed in human monocytes [34]. Members of the
let-7 miRNA family were shown to be down-regulated uponSalmonella infection both in macrophages and in epithelial cells
[33], suggesting that repression of this miRNA family
constitutes a common signature of the infection of phagocytic
and non-phagocytic cells by Salmonella. The let-7 family targets
two major immunomodulatory cytokines: the pro-inﬂammatory
cytokine IL-6 and the anti-inﬂammatory cytokine IL-10 [33,35].
Thus, Salmonella infection, through the inhibition of let-7, induces
the expression of both cytokines resulting in a balanced inﬂamma-
tory response.
In recent studies, we observed that Salmonella infection also
down-regulates the miR-15 family in HeLa cells [36]. Interestingly,
overexpression of miR-15 family members inhibits Salmonella
infection very efﬁciently, through repression of Cyclin D1 (CCND1),
a protein required for G1/S transition. Of note, we showed
that down-regulation of miR-15 by Salmonella favors cell cycle
progression and, ultimately, bacterial replication.
The effect of Salmonella infection on miRNA expression has also
been studied in vivo, in piglets and zebraﬁsh embryos. In the ileum
of infected piglets, Salmonella induces miR-29a expression as early
as 3 h post-infection [37]. MiR-29a was shown to target Caveolin-2
(CAV2), an inhibitor of the small Rho GTPase CDC42, which plays
an essential role in Salmonella invasion of epithelial cells [38].
Infection of zebraﬁsh embryos with Salmonella induces expression
of miR-146a/b, miR-21 and miR-29a [39]. In zebraﬁsh embryos,
miR-146a/b down-regulation by Salmonella infection had no major
effect on canonical pro-inﬂammatory genes, except for the up-reg-
ulation of apolipoprotein genes that have been previously linked to
immunoregulation and host defense [40,41].
5. Helicobacter pylori
H. pylori, a highly prevalent Gram-negative pathogen estimated
to chronically infect the gastric mucosa of roughly half the world’s
population, is the primary etiological cause of gastritis, peptic ulcer
and gastric cancer [42].
The ﬁrst evidence of mammalian host miRNA regulation during
infection by bacterial pathogens was obtained using H. pylori infec-
tion as a model [43]. In a pioneering study, Zhang et al. revealed
that expression of miR-21 is increased upon H. pylori infection
and provided evidence that miR-21 induces host cell proliferation,
suggesting that miR-21 could constitute a link between H. pylori
infection and gastric cancer progression.
Several studies reported that the immune-related miRNA miR-
155 is strongly up-regulated upon H. pylori infection, both
in vitro (epithelial cells, lymphocytes and macrophages [44–46])
and in vivo (human biopsies of infected gastric mucosa [44,46–
48]). Induction of miR-155 was shown to be dependent on LPS
sensing by TLR4 and consequent NF-jB pathway activation
[45,46], as well as on bacterial toxins secreted through the type-
IV secretion system, in particular the vacuolating toxin A (VacA)
and the c-Glutamyl transpeptidase [44]. Interestingly, miR-155
knockout mice fail to control H. pylori infection, due to impaired
Th1 and Th17 responses, but are less susceptible to H. pylori-
induced gastritis and gastric cancer [48]. Induction of miR-155
negatively regulates the release of IL-8 triggered by infection, sug-
gesting that miR-155 could function as a negative regulator to ﬁne-
tune inﬂammatory responses towards H. pylori [46]. In macro-
phages, miR-155 was also shown to target genes involved in
DNA damage response, and could therefore be involved in
enhanced resistance to apoptosis upon DNA damage induced by
H. pylori [45]. MiR-146a, other NF-jB-dependent miRNA, was also
shown to be induced upon H. pylori infection both in vitro and
in vivo [49–51]. This miRNA was shown to negatively regulate
inﬂammatory responses directed against H. pylori through modula-
tion of IRAK1, TRAF6 and PTGS2 [49–51]. Like miR-155, miR-146a
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inﬂammatory responses to H. pylori.
In addition to the regulation of miR-155 and miR-146a/b, a
common response to Gram-positive and Gram-negative pathogens
is the down-regulation of the let-7 miRNA family. H. pylori was
shown to decrease let-7 expression in vitro and in vivo through
its major virulence factor CagA [52,53]. Down-regulation of the
let-7 family leads to the de-repression of their target TLR4 and thus
potentiates the NF-jB inﬂammatory response. Balance between
the expression of miR-155, miR-146a/b and the let-7 family
appears to be therefore critical to control H. pylori-induced
inﬂammation.
A distinguishing feature of H. pylori is its ability to induce carci-
nogenesis [42]. Potential roles of miRNAs in this process have been
investigated by several groups. H. pylori can induce the expression
of miR-21 and miR-222, two miRNAs that target RECK, a
known tumor suppressor [43,54]. Relevant to the possible contri-
bution of miR-21 and miR-222 to tumor progression, it has been
shown that overexpression of these miRNAs induces proliferation
of gastric epithelial cells. In addition to down-regulation of the
let-7 family, the virulence factor CagA was also shown to down-
regulate miR-370 and miR-320, two miRNAs involved in tumor
suppression [55,56]. miR-370 inhibits cell proliferation through
the down-regulation of FoxM1 and consequent activation of the
cell cycle inhibitor p27KIP1; down-regulation of miR-370 in infected
cells can thus lead to increased cell proliferation [55]. Expression of
MCL1, a target of miR-320 and a known anti-apoptotic gene, is
increased in H. pylori-infected cells, thus preventing apoptosis
and potentially increasing the risk of carcinogenesis [56]. CagA
was also shown to stimulate the expression of miR-584 and
miR-1290, which target FOXA1, a negative regulator of the
epithelial-mesenchymal transition (EMT) [57]. These observations
linking H. pylori infection, in particular the secretion of the CagA
virulence factor, with the dedifferentiation of gastric epithelial
cells and EMT, constitute another mechanism that can potentially
contribute to carcinogenesis induced by H. pylori. On the other
hand, Belair et al. showed that H. pylori can interfere with miRNA
expression to block cell cycle progression [58]. These authors
showed that H. pylori infection of gastric epithelial cells causes
down-regulation of miR-372 and miR-373 via CagA leading to
the de-repression of their target LATS2, a tumor suppressor, and
thus to cell cycle arrest at the G1/S transition. Although in vivo evi-
dence is still lacking, this process might be a mechanism used by H.
pylori to inhibit gastric epithelium renewal as a host defense mech-
anism against bacterial infection. Although the processes leading
to carcinogenesis and tumor progression upon H. pylori infection
remain controversial and highly debated, these studies have
uncovered several mechanisms by which miRNAs can possibly
contribute to these phenomena.
H. pylori has also been shown to manipulate host miRNA
expression for its own beneﬁt. H. pylori infection induces miR-
30b expression in AGS cells and in gastric tissues [59]. This miRNA
targets ATG12 and BECN-1, two main players of the autophagy
pathway, and miR-30b up-regulation can thus allow H. pylori to
evade clearance by autophagy in infected cells. Notably, H. pylori
can also favor its own colonization of the gastric epithelium by
inducing a transient hypochlorhydria, i.e. decrease of gastric acid-
iﬁcation, through the up-regulation of miR-1289 and the conse-
quent repression of HKa, one of the subunits of the gastric H+/K+
ATPase [60].
6. Mycobacterium species
Tuberculosis (TB) remains a major public health challenge glob-
ally, estimations indicating that roughly one third of the world’s
population has been infected with M. tuberculosis, with 1.5 millionassociated deaths occurring annually [61]. The genus Mycobacte-
rium includes highly pathogenic species such as the etiological
agent of TB, M. tuberculosis, and Mycobacterium leprae (responsible
for leprosy), but also opportunistic pathogens such as Mycobacte-
rium avium, which can affect immunocompromised individuals
[62].
Similarly to other pathogenic bacteria, Mycobacterium species
can modulate expression of miR-155 upon infection [63–67].
Mycobacterium bovis infection was shown to up-regulate miR-155
expression in macrophages, through TLR2 and NF-jB signaling,
leading to increased apoptosis of infected cells [63]. In a different
study, Rajaram et al. established a link between virulence of Myco-
bacterium species, production of TNF-a and the differential expres-
sion of miR-155 and miR-125b [65]. TNF-amRNA is a direct target
of miR-125b, whereas miR-155 can stimulate TNF-a synthesis
through its target SHIP1, a negative regulator of the PI3K/AKT path-
way. Interestingly, stimulation of cells with lipomannan, a compo-
nent of the bacterial cell wall, from either a virulent strain (M.
tuberculosis) or an avirulent strain (Mycobacterium smegmatis)
leads to opposing effects on TNF-a synthesis: lipomannan from
M. tuberculosis inihibits TNF-a synthesis, whereas that from M.
smegmatis induces its expression. This phenomenon is dependent
on the balance between miR-155 and miR-125b levels:M. tubercu-
losis induces comparatively high levels of miR-155 and low levels
of miR-125b whereas M. smegmatis induces low levels of miR-
155 and high levels of miR-125b. Whether stimulation of miR-
155 expression is favorable or detrimental for Mycobacterium
infection remains unclear. For instance, Kumar et al. showed that,
in mouse macrophages, M. tuberculosis can modulate the cell envi-
ronment for its own beneﬁt via induction of miR-155 expression,
through the virulence-associated secreted protein ESAT-6 [64].
Indeed, miR-155 up-regulation can activate the AKT pathway
which is required for M. tuberculosis survival in macrophages and
inhibit the synthesis of the pro-inﬂammatory cytokine IL-6. In
another study, Wang et al. showed that up-regulation of miR-155
can be detrimental for M. tuberculosis infection in mouse macro-
phages, by activating the autophagy pathway [67]. MiR-155 can
induce autophagy through the repression of the negative regulator
Rheb, and of other components of the mTOR signaling pathway
[67,68].
Other miRNAs, such as miR-142-3p, are differently regulated
upon infection by different species ofMycobacterium. On one hand,
this miRNA is strongly up-regulated upon M. tuberculosis and M.
smegmatis infection of macrophages and this limits bacterial phag-
ocytic uptake by targeting N-Wasp, an actin-binding protein
required for invasion [69]. On the other hand, expression of miR-
142-3p is strongly inhibited upon M. bovis infection, resulting in
the activation of the NF-jB pathway via the de-repression of the
target IRAK1 [70].
Mycobacterium species can also subvert miRNAs to evade host
immune responses. As for other pathogenic bacteria, Mycobacte-
rium infection leads to the up-regulation of the immune-related
miRNAs miR-21 and miR-146a both in vitro and in vivo [66,70–
74]. In particular,M. boviswas shown to induce miR-21 expression
in a NF-jB-dependent manner in T-cells and dendritic cells (DC),
leading to inhibition of IL-12 production [74]. Up-regulation of
miR-21 was also shown to promote apoptosis in DC, through tar-
geting of Bcl2. M. bovis can, by increasing miR-21 expression,
impair anti-mycobacterial Th1 response. M. leprae can also induce
miR-21 expression in infected monocytes and macrophages. These
cells rely on the vitamin D-dependent antimicrobial pathway to
clear infections and by targeting CYP27B1 and IL-1b, miR-21 can
inhibit the synthesis of two vitamin D-dependent antimicrobial
peptides and therefore allow M. leprae to persist in infected cells
[72]. In macrophages and DC, M. tuberculosis infection strongly
increases miR-99b expression, dampening the inﬂammatory
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of miR-99b and inhibition of this miRNA activates the production
of TNF-a, and indirectly of other inﬂammatory cytokines (IL-6,
IL-12 and IL-1b).
Similarly to what was observed for Listeria infection, expression
of miR-29 is down-regulated in IFN-c-producing NK cells upon M.
bovis infection [28]. Inhibition of miR-29 was shown to potentiate
the immune response directed against M. bovis thus enabling a
more effective clearance of the bacteria. On the contrary, expres-
sion of miR-29a, as well as of let-7e, is induced upon M. avium
infection of macrophages, resulting in inhibition of the infection-
induced apoptosis via targeting of Caspase-3 and Caspase-7 [66].
Overall, and as observed for other pathogens, the T-cell
response to pathogenic Mycobacterium infection appears
signiﬁcantly different from that of myeloid cells, in terms of miRNA
regulation. Indeed, miR-21, miR-29a and miR-142-3p, which are
up-regulated by Mycobacterium in macrophages [69,71,72,75], are
strongly down-regulated upon infection in T-cells [76], further
highlighting that miRNA expression and miRNA regulation are
highly dependent on the cell context.
7. Other bacterial pathogens
The central role of miR-155 in the immune response triggered
by pathogenic bacteria is now well established for Salmonella, Lis-
teria, Helicobacter andMycobacterium and evidence of its regulation
by other bacteria is accumulating. For example, miR-155 appears
to be a critical player in the host response to Citrobacter rodentium,
a Gram-negative bacteria that causes enteritis, since miR-155
knockout mice are unable to clear infection by this bacteria [77].
The Staphylococcal enterotoxin B (SEB), an exotoxin secreted by
Staphylococcus aureus, can cause food poisoning, lung injury and
respiratory failure by triggering an acute inﬂammatory response
[78]. This toxin induces a very strong increase of miR-155 expres-
sion that leads to accumulation of IFN-c and abnormal inﬂamma-
tory responses [79]. Interestingly, miR-155 knockout mice are
protected against all deleterious effects of SEB, suggesting a pivotal
role of this miRNA in the pathogenicity of SEB and more broadly of
S. aureus. Differential regulation of miR-155 has also been linked to
the virulence properties of two subspecies of Francisella tularensis,
a Gram-negative bacteria that causes tularemia. The low virulent
subspecies, F. tularensis subspecies F. novicida, strongly increases
miR-155 expression, inducing a strong inﬂammatory response via
the activation of the PI3K/AKT pathway, while the highly virulent
subspecies, F. tularensis subspecies tularensis, does not induce
miR-155 expression and thus triggers only a mild inﬂammatory
response, possibly explaining its high virulence [80,81].
In addition to the bacterial pathogens described above, system-
atic proﬁling of host miRNA expression has been applied to other
bacterial pathogens. For example, infection by Brucella melitensis,
a Gram-negative facultative intracellular bacteria causing brucello-
sis, induces changes in the expression of several miRNAs (e.g. let-
7b, miR-92a, miR-93, miR-181b and miR-1981) [82]. These have
putative targets involved in apoptosis, autophagy and immune
response. In a different study, miRNA proﬁling upon infection with
the Gram-positive bacteria Streptococcus uberis suggested that,
besides the NF-jB-associated miRNAs, the miRNA response to
Gram-positive bacteria is markedly different to the response to
LPS of Gram-negative bacteria [83]. Only 9 of the 21 miRNAs reg-
ulated most strongly upon S. uberis infection have also been
reported to be regulated upon LPS stimulation; with 5 of these 9
miRNAs showing an inverse response to S. uberis infection in
comparison to LPS. The expression of miRNAs upon infection
of mouse alveolar macrophages with the Gram-negative
bacteria Pseudomonas aeruginosa revealed that 8 miRNAs wereup-regulated in macrophages, with miR-302b being the most sig-
niﬁcantly increased. The up-regulation of miR-302b results in the
dampening of the inﬂammatory response via its target IRAK4, an
activator of the NF-jB pathway [84].
Increasing evidence also supports a link between autophagy,
miRNA regulation and bacterial infection, as described above for
Helicobacter and Mycobacterium. The Crohn’s disease associated
adherent-invasive Escherichia coli can also interfere with the
autophagy pathway through the up-regulation of miR-30c and
miR-130a, which target two key regulators of the autophagy path-
way – ATG5 and ATG16L1 [85].
8. Interplay between host miRNAs and gut microbiota
The gastrointestinal tract of mammals is colonized by a large
microbial population. Increasing evidence suggests an essential
role for the gut microbiota in the establishment and maintenance
of an appropriate gut mucosa homeostasis. A growing number of
disorders have been linked to gut microbiota dysbiosis, including
gastrointestinal diseases (e.g. bowel disease), cancer, cardiovascu-
lar diseases and obesity. Although it is not surprising that the res-
ident microbiota modulates host gene expression, the role of
miRNAs in the interplay between the gut microbiota and the host
is just beginning to be explored (reviewed in [86]).
Several studies have tackled this question by performing com-
parative analysis of miRNA expression of germ-free mice and mice
colonized with the microbiota from pathogen-free mice. Dalmasso
et al. identiﬁed 9 miRNAs differentially expressed in colonized
mice relative to germ-free mice: miR-298 (ileum) and miR-128,
miR-200c⁄, miR-342-5p, miR-465c-5p, miR-466d-3p, miR-466d-
5p, miR-665 and miR-68 (colon) [87]. One of these miRNAs, miR-
665, was shown to target the ATP-binding cassette sub-family C
member 3 (Abcc3), which encodes for a protein associated with
multidrug resistance, involved in the metabolism of xenobiotic
and endogenous toxins. Colonization of mice with microbiota
decreases the expression of miR-665 thus increasing Abcc3 expres-
sion, with likely consequences in xenobiotic metabolism. A similar
study by Singh et al. using germ-free mice and conventionally
raised mice, showed that the endogenous microbiota also impacts
the expression of miRNAs in the caecum (16 miRNAs differentially
regulated) [88]. Various putative target genes of the deregulated
miRNAs encode for proteins involved in the regulation of intestinal
barrier function and immune regulation. Xue et al. reported that
the microbiota negatively regulates miR-10 expression in the
intestinal epithelial cells and dendritic cells, through a MyD88-
dependent pathway [89]. Taking into consideration that the IL-
12/IL-23 p40 subunit, a key regulator of innate immune responses
against commensal bacteria, was identiﬁed as a target of miR-10, it
is likely that this miRNA is involved in the maintenance of host
immune homeostasis. Interestingly, a mouse model of colitis also
expressed lower levels of miR-10 compared with control mice,
and conversely high levels of IL-12/IL-23 p40. Although these stud-
ies provide compelling evidence that the intestinal microbiota
induces differential expression of miRNAs, further studies are nec-
essary to conclusively address howmiRNAmodulation impacts the
gut homeostasis.
Recently, two reports analyzed if miRNA modulation through
the gut microbiota is affected during infection by a bacterial path-
ogen, and whether this has consequences for the host transcrip-
tome. Treatment with the probiotic Lactobacilli species
(Lactobacillus casei and Lactobacillus paracasei) was able to limit L.
monocytogenes dissemination in a gnotobiotic humanized mouse
model [90]. This effect correlated with changes in the transcrip-
tome of the host (in particular IFN-stimulated genes) as well as
of L. monocytogenes (e.g. propanediol and ethanolamine catabolism
UpregulatedDownregulated No change
Listeria monocytogenes
conventional germ-free
miR-143
miR-148a
miR-200b
miR-200c
miR-143
miR-148a
miR-200b
miR-200c
miR-194
miR-378
miR-194
miR-378
Fig. 2. Role of gut microbiota in the regulation of miRNA expression during Listeria
infection (cf. Ref. [29]).
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Lactobacillus also leads to changes in host miRNAs, with a higher
expression of miR-200b, miR-215, and miR-192, which are nor-
mally repressed during L. monocytogenes infection and to a lower
expression of miR-181b, which does not vary during infection
[90]. Putative targets of these miRNAs include the NOD-like recep-
tor NLR5, several GTPases and members of the Schlafen family
involved in cell growth and T-cell development. The general role
of the intestinal microbiota in the regulation of miRNA expression
during Listeria infection has been also analyzed through the com-
parison of miRNA signatures in the ileum of conventional and
germ-free mice, infected or not with L. monocytogenes [29].
Although the intestinal miRNA signature is globally stable in the
different conditions, the expression levels of 6 miRNAs (miR-143,
miR-148a, miR-194, miR-200b, miR-200c, and miR-378) were sig-
niﬁcantly decreased upon L. monocytogenes infection in conven-
tional mice. The expression of 4 of these miRNAs (miR-143, miR-
148a, miR-200b and miR-200c) decreased only in conventional
mice, whereas miR-378 was decreased in conventional mice and
increased in germ-free mice (Fig. 2). Several candidate target genes
whose expression inversely correlated with the expression of these
miRNAs were identiﬁed; however, their relevance in the context of
host-pathogen interplay has yet to be addressed. These results
reveal an interesting microbiota-dependent regulation of miRNA
expression upon Listeria infection, suggesting a role for microbiota
in the reprogramming of host gene expression during infection by
bacterial pathogens, likely with relevant implications to the
success of infection.
9. Perspective
Advancements in RNA-sequencing have enabled the systematic
proﬁling of the miRNome changes upon infection by different bac-
terial pathogens, as illustrated above for Listeria, Salmonella, Helico-
bacter, Mycobacteria and other pathogens. These analyses have
revealed a common set of miRNAs as key players in the host innate
immune response against bacteria, speciﬁcally miR-146, miR-155,
miR-21, miR-125 and let-7. Concurrently, it has also become clear
that closely related species such as M. tuberculosis, M. smegmatis,M. bovis and M. avium or F. tularensis and F. novicida, regulate a
different subset of host miRNAs. Another very important concept
that has emerged from these studies is that changes in miRNA
expression following exposure or infection to different bacteria is
highly dependent on the cell context, with different cell types
responding very differently to the same pathogen. Of note, the
mechanisms underlying the vast majority of the bacterial-induced
miRNA expression changes described above are not fully under-
stood. In this context, the existence of bacterial effector protein(s)
that, once secreted into host cells, might act as RNA silencing sup-
pressors/activators to directly or indirectly manipulate the host
miRNA pathway is a fascinating hypothesis. Similar factors have
been characterized in viruses and in the bacterial plant pathogen
P. syringae, however are yet to be identiﬁed in bacterial pathogens
that infect mammals. Another intriguing hypothesis is that silenc-
ing suppressors may derive from RNAs rather than from proteins.
Indeed, a mechanism by which viral RNAs can directly mediate
the degradation of speciﬁc host miRNAs has been reported for Her-
pesvirus and cytomegalovirus [91–93]. Recently, E. coli endoge-
nous non-coding RNAs, OxyS and DsrA, were shown to impact on
the physiology of Caenorhabditis elegans, through the down-regula-
tion of speciﬁc C. elegans genes [94].
While the characterization of changes in the expression of host
miRNAs during infection by several bacterial pathogens is now
well under way, signiﬁcantly less is known about the role of miR-
NAs in modulating bacterial infection. Notwithstanding the emer-
gence of congruent regulations, such as those of host inﬂammatory
response, autophagy and cell cycle pathways, a more detailed anal-
ysis of the effect of miRNAs in host-pathogen interaction is neces-
sary. Along this line, given the putative involvement of miRNAs in
different steps of the host response to bacterial infections, the pos-
sibility to manipulate bacterial infections by modulating the levels
of host cell miRNAs is an attractive concept, with obvious thera-
peutic applications. We have recently undertaken a systematic
approach to identify miRNAs regulating infection by Salmonella
Typhimurium, using a ﬂuorescence microscopy-based screening
of a library of miRNA mimics [36]. Using this approach, we identi-
ﬁed 17 miRNAs that decrease and 11 miRNAs that increase Salmo-
nella infection by at least 2-fold, providing evidence that miRNAs
can be used to modulate infection by bacterial pathogens. Among
the miRNAs that decrease infection more efﬁciently, we identiﬁed
the miR-15 family, which is down-regulated upon Salmonella infec-
tion, thus showing an active role of Salmonella in down-regulating
host miRNAs that counteract infection, to promote its own survival
and replication [36].
The presence of miRNAs in the bloodstream and other body ﬂu-
ids and, most importantly, the recognition that the pool of circulat-
ing miRNAs does not mirror the relative abundance of intracellular
miRNAs, implying a selective mechanism of miRNA secretion, has
raised interest in the use of miRNAs as diagnostic markers. Analysis
of circulating miRNAs in the serum of individuals infected with M.
tuberculosis identiﬁed 59 up-regulated miRNAs and 33 down-regu-
lated [75]. Among the up-regulated miRNAs, miR-29a was
described as a potential diagnosis marker to discriminate tubercu-
losis patients from healthy individuals. An intriguing hypothesis is
that secreted miRNAs, associated with AGO2 in nuclease-resistant
complexes or in small membrane vesicles denominated exosomes,
can participate in long-range signaling events [95], preparing the
host neighboring tissues to counteract infections or, on the other
hand, facilitating the spreading of infections by making neighbor-
ing tissues more susceptible. Supporting the ﬁrst hypothesis, it
has been shown that T-cells can transfer miRNAs to antigen-pre-
senting cells via exosomes, suggesting that intercellular miRNA
transfer may contribute to coordinate and/or ﬁne-tune gene
expression during the onset of the immune response [96]. The
4146 C. Maudet et al. / FEBS Letters 588 (2014) 4140–4147extent and relevance of these miRNA-mediated signaling events to
the outcome of different bacterial infections remains, nonetheless,
to be fully investigated.
In addition to bacterial pathogens, commensal bacteria as part
of the gut microbiota have also been shown to interfere with host
miRNA expression both in the absence of a pathogen, as well as
upon infection with the foodborne pathogen L. monocytogenes.
More studies are required to better understand the role of miRNA
modulation triggered by microbiota in the reprogramming of host
gene expression and their implications to gut homeostasis and/or
infections by bacterial pathogens.
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